Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
Will Parsons, Interim Director at Texas Children’s Cancer and Hematology Center, shared a post on LinkedIn:
”We’re proud to recognize the national leadership roles of (pictured L-R) Drs. Titilope Fasipe, Jacquelyn “Jackie” Powers and Venee Tubman in advancing care for children with blood disorders.
• Dr. Titi Fasipe serves as Chair of the National Heart, Lung, and Blood Institute (NHLBI) Sickle Cell Disease Advisory Committee and leads two American Society of Hematology (ASH) initiatives focused on community engagement and quality care.
• Dr. Jackie Powers is Clinical Chair for ASH’s guidelines on pediatric iron deficiency, one of the few national efforts focused on children.
• Dr. Tubman leads ASH’s global guidelines on hydroxyurea dosing and monitoring, helping standardize care for children with chronic blood disorders around the world.
Please join us in celebrating their continued leadership and impact on the lives of children and families affected by blood disorders.
The NHLBI is part of the The National Institutes of Health and is focused on advancing research and education on the prevention and treatment of heart, lung, blood and sleep disorders.
ASH is the world’s largest professional organization dedicated to advancing the understanding, diagnosis, treatment and prevention of blood and bone marrow disorders through transformative research, innovative education, and high-quality, equitable care.
Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center are joining forces to launch the Kinder Children’s Cancer Center in 2026.”
Learn more on this initiative here.
Stay updated on the global initiatives in the World of Hematology with Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25